Pfam Domains GO Terms
| 7TM GPCR Srsx |
| 7tm 1 |
| angiotensin type I receptor activity |
| phospholipase C-activating angiotensin-activated signaling pathway |
| bradykinin receptor binding |
| angiotensin type II receptor activity |
| renin-angiotensin regulation of aldosterone production |
| renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure |
| regulation of blood vessel diameter by renin-angiotensin |
| regulation of aldosterone secretion |
| regulation of mineralocorticoid secretion |
| positive regulation of phospholipase A2 activity |
| positive regulation of NAD(P)H oxidase activity |
| regulation of blood volume by renin-angiotensin |
| positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| positive regulation of cholesterol esterification |
| angiotensin-activated signaling pathway |
| regulation of cholesterol esterification |
| regulation of NAD(P)H oxidase activity |
| regulation of phospholipase A2 activity |
| low-density lipoprotein particle remodeling |
| regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| positive regulation of macrophage derived foam cell differentiation |
| regulation of corticosteroid hormone secretion |
| regulation of steroid hormone secretion |
| regulation of renal sodium excretion |
| cellular response to angiotensin |
| regulation of systemic arterial blood pressure by renin-angiotensin |
| renal system process involved in regulation of systemic arterial blood pressure |
| regulation of excretion |
| response to angiotensin |
| positive regulation of steroid metabolic process |
| plasma lipoprotein particle remodeling |
| protein-lipid complex remodeling |
| protein-containing complex remodeling |
| regulation of macrophage derived foam cell differentiation |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway |
| regulation of renal system process |
| regulation of systemic arterial blood pressure by hormone |
| positive regulation of sprouting angiogenesis |
| plasma lipoprotein particle organization |
| regulation of endocrine process |
| regulation of systemic arterial blood pressure mediated by a chemical signal |
| protein-lipid complex subunit organization |
| endocrine process |
| positive regulation of oxidoreductase activity |
| regulation of vasoconstriction |
| positive regulation of phospholipase activity |
| regulation of sprouting angiogenesis |
| positive regulation of lipase activity |
| regulation of phospholipase activity |
| regulation of plasma lipoprotein particle levels |
| Rho protein signal transduction |
| regulation of systemic arterial blood pressure |
| positive regulation of endothelial cell proliferation |
| phospholipase C-activating G protein-coupled receptor signaling pathway |
| positive regulation of reactive oxygen species metabolic process |
| regulation of oxidoreductase activity |
| regulation of lipase activity |
| regulation of lipid transport |
| renal system process |
| regulation of steroid metabolic process |
| regulation of endothelial cell proliferation |
| regulation of lipid localization |
| regulation of blood vessel diameter |
| regulation of tube diameter |
| positive regulation of inflammatory response |
| regulation of tube size |
| positive regulation of lipid metabolic process |
| calcium-mediated signaling |
| positive regulation of angiogenesis |
| vascular process in circulatory system |
| regulation of reactive oxygen species metabolic process |
| regulation of blood pressure |
| positive regulation of vasculature development |
| positive regulation of epithelial cell proliferation |
| cell chemotaxis |
| Ras protein signal transduction |
| cellular response to peptide hormone stimulus |
| regulation of hormone secretion |
| kidney development |
| positive regulation of cytosolic calcium ion concentration |
| renal system development |
| regulation of angiogenesis |
| regulation of blood circulation |
| urogenital system development |
| small GTPase mediated signal transduction |
| regulation of vasculature development |
| cellular response to peptide |
| regulation of cytosolic calcium ion concentration |
| regulation of epithelial cell proliferation |
| second-messenger-mediated signaling |
| regulation of inflammatory response |
| extracellular structure organization |
| blood circulation |
| response to peptide hormone |
| circulatory system process |
| regulation of lipid metabolic process |
| regulation of cell growth |
| cellular calcium ion homeostasis |
| calcium ion homeostasis |
| cellular divalent inorganic cation homeostasis |
| response to peptide |
| positive regulation of defense response |
| protein heterodimerization activity |
| divalent inorganic cation homeostasis |
| inflammatory response |
| regulation of anatomical structure size |
| regulation of hormone levels |
| chemotaxis |
| taxis |
| cellular metal ion homeostasis |
| regulation of system process |
| cellular response to organonitrogen compound |
| positive regulation of response to external stimulus |
| cellular response to hormone stimulus |
| metal ion homeostasis |
| cellular cation homeostasis |
| cellular ion homeostasis |
| cellular response to nitrogen compound |
| regulation of growth |
| cation homeostasis |
| inorganic ion homeostasis |
| G protein-coupled receptor activity |
| cellular chemical homeostasis |
| regulation of secretion by cell |
| regulation of defense response |
| positive regulation of hydrolase activity |
| ion homeostasis |
| regulation of secretion |
| cellular homeostasis |
| response to hormone |
| positive regulation of cell population proliferation |
| cell migration |
| positive regulation of cell differentiation |
| response to organonitrogen compound |
| cellular response to oxygen-containing compound |
| regulation of anatomical structure morphogenesis |
| cell motility |
| localization of cell |
| response to nitrogen compound |
| regulation of response to external stimulus |
| chemical homeostasis |
| cellular response to endogenous stimulus |
| regulation of hydrolase activity |
| locomotion |
| G protein-coupled receptor signaling pathway |
| defense response |
| positive regulation of developmental process |
| integral component of plasma membrane |
| positive regulation of catalytic activity |
| response to endogenous stimulus |
| regulation of response to stress |
| movement of cell or subcellular component |
| response to oxygen-containing compound |
| positive regulation of cellular protein metabolic process |
| regulation of cell population proliferation |
| homeostatic process |
| intracellular signal transduction |
| positive regulation of protein metabolic process |
| positive regulation of multicellular organismal process |
| positive regulation of molecular function |
| regulation of cell differentiation |
| protein-containing complex subunit organization |
| regulation of transport |
| system process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| MS023 2μM R03 exp134 | 1.73 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution